1 min read
The U.S. FDA has been evaluating reports of suicidal thoughts or actions in patients treated with a class of medicines called GLP-1 receptor agonists, used to treat DM2 or obesity . The preliminary evaluation has not found evidence that use of these medicines causes suicidal thoughts or actions.
reddit.com
Saturday, January 31, 2026
  submitted by   /u/Dr_Neurol [link]   [comments]
 | submitted by /u/Dr_Neurol [link] [comments] |
Read the full article
Continue reading on reddit.com
More from reddit.com
1 hours ago
« Ce que je veux de Paris, c’est toi » : le patron des Jeux olympiques de Los Angeles 2028 cité dans l’affaire Epstein
1 hours ago
US-Star bangt um Olympia: Nach dem Sturz: Weiteres Update von Ski-Star Vonn
1 hours ago
Nigerian Army launches forest operation, dislodges bandits in Kwara
1 hours ago